Carboplatin/Nab-Paclitaxel/Pembrolizumab Regimen

Preferred Label : Carboplatin/Nab-Paclitaxel/Pembrolizumab Regimen;

NCIt synonyms : Nab-Paclitaxel-Carboplatin-Pembrolizumab Regimen; Abraxane/Carboplatin/Keytruda; Albumin-bound Paclitaxel-Carboplatin-Pembrolizumab; Albumin-bound Paclitaxel-Carboplatin-Pembrolizumab Regimen;

NCIt related terms : Carboplatin, nab-Paclitaxel, Pembrolizumab;

NCIt definition : A regimen consisting of carboplatin, nab-paclitaxel, and pembrolizumab that can be used in the treatment of metastatic squamous non-small cell lung cancer (NSCLC).;

NCI Metathesaurus CUI : CL937184;

Codes from synonyms : 30166;

Details

Origin ID

C157619;

UMLS CUI

C4761395;

Est indiqué pour
- Metastatic Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
See also (suggested by CISMeF)
- Metastatic Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Nab-paclitaxel [NCIt concept]
- Pembrolizumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Lung Non-Small Cell Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients